Human Anti-SLAMF7 Recombinant Antibody (clone Ilofuzumab)

This product is a recombinant antibody that recognizes SLAMF7. The monoclonal antibody Ilofuzumab reacts with the epitope of SLAMF7. A combination of Ilofuzumab and wherein -PD1 antibody showed a synergistic anti-tumor activity.
Supplier Creative Biolabs
Product # HPAB-642-FY
Pricing Inquiry
Host Human
Target SLAMF7
Species Reactivity Human
Type Humanized IgG2a
Applications Activ
Storage Centrifuge briefly prior to opening vial. Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.
Feedback